Study objective This systematic review and meta-analysis aimed to assess the efficacy and
safety profile of treatment with inclisiran, a drug that has been recently approved by the …

Introduction: Statins are powerful lipid-lowering agents which reduce cardiovascular (CV)–
related morbidity and mortality. However, a large proportion of patients cannot attain the …

Background In hypercholesteremia, the concentrations of total cholesterol (TC) and low-
density lipoprotein cholesterol (LDL-C) are enhanced in serum, which is strongly associated …

Objectives: Identify indications for initiating statin therapy. Review contraindications for statin
therapy. Explain common and uncommon adverse effects associated with statin therapy …

Background Emergency percutaneous coronary intervention (PCI) can quickly restore
myocardial perfusion after acute coronary syndrome. Whether and which lipid-lowering …

Introduction: Reducing low-density lipoprotein cholesterol (LDL-C) with lipid-lowering
therapies has been associated with a decrease in the frequency of cardiovascular events …

Introduction Individuals diagnosed with atherosclerotic cardiovascular disease (ACD) are
exposed to an increased risk of cardiovascular events. Reducing low-density lipoprotein …

Abstract In July 2022, the World Health Organization announced monkeypox as a public
health emergency of international concern (PHEIC), and over 85,000 global cases have …

Purpose We investigated whether the combination therapy of low-intensity rosuvastatin and
ezetimibe is an useful alternative to moderate-intensity rosuvastatin monotherapy in patients …

A large percentage (~ 60%) of prescription drugs and new molecular entities are designed
for oral delivery, which requires passage through a semi-impervious membrane bilayer in …